Long-term course of ambulatory patients with COVID-19 initially treated with enoxaparin vs no anticoagulation: final analysis of the OVID (enoxaparin for outpatients with COVID-19) randomized trial
Titel:
Long-term course of ambulatory patients with COVID-19 initially treated with enoxaparin vs no anticoagulation: final analysis of the OVID (enoxaparin for outpatients with COVID-19) randomized trial
Auteur:
Fumagalli, Riccardo M. Voci, Davide Bikdeli, Behnood Bingisser, Roland Colucci, Giuseppe Forgo, Gabor Gerardi, Teresa Gerber, Bernhard Grigorean, Alexandru Klok, Frederikus A. Righini, Marc Robert-Ebadi, Helia Stortecky, Stefan Ulrich, Silvia Wolf, Simon Wyss, Dörte Hobohm, Lukas Kucher, Nils Barco, Stefano
Verschenen in:
Research and practice in thrombosis and haemostasis